AstraZeneca posts mixed lung‑cancer trial updates
Drugmaker AstraZeneca posted two contrasting lung‑cancer updates on Monday, discontinuing one Phase III study while reporting strong survival…
AstraZeneca reports first-half growth, disappointment in Ultomiris trial
AstraZeneca reported first-half total revenue of $30.7bn on Monday, up 9%, while core earnings per share increased 12%…
GSK rectal cancer drug shows positive result in key trial
A treatment for rectal cancer being developed by GSK has shown positive results in interim testing, the pharma…
Iran International journalist Pouria Zaratifoukolaei stabbed in London at behest of Iran, court told
A team of Romanian men, acting as proxies for the Iranian government, carried out a knife attack on…
News – Volunteers needed for vaccine study preparing for a potential bird flu pandemic
Wednesday, 29 April 2026
Volunteers are needed for a new trial looking for an effective…